Related Experiment Video
Updated: Jun 11, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network
Wallace Crandall1, Michael D Kappelman, Richard B Colletti
1Division of Pediatric Gastroenterology, Nationwide Children's Hospital, Columbus, Ohio 43205, USA. Wallace.crandall@nationwidechildrens.org
Insights
Quality improvement methods reduce variations in pediatric inflammatory bowel disease (IBD) care. The ImproveCareNow Network shows success in enhancing diagnostic testing, treatment, and patient outcomes through collaborative data sharing and evidence-based strategies.
Area of Science:
- Pediatric Gastroenterology
- Quality Improvement Science
- Healthcare Management
Background:
- Significant variability exists in diagnostic testing and treatment protocols for pediatric inflammatory bowel disease (IBD).
- Unwarranted variations in care can negatively impact patient outcomes.
- Quality improvement (QI) science offers a framework to standardize and enhance healthcare delivery.
Purpose of the Study:
- To implement and evaluate a multicenter collaborative network model for improving pediatric IBD care.
- To address variations in diagnostic testing, disease classification, nutrition, and medication management.
- To demonstrate the effectiveness of QI methods in a subspecialty care setting.
Main Methods:
- Establishment of the ImproveCareNow Network, a collaborative of pediatric subspecialists.
- Utilization of patient registries for data collection and performance monitoring.
- Implementation of evidence-based chronic illness care strategies, including population management and decision support.
Main Results:
- Enrollment of patients across 23 sites, with data analyzed from over 2500 patients and 7500 visits.
- Demonstrated improvements in care processes, such as appropriate medication dosing and comprehensive disease classification.
- Observed positive outcomes, including an increased percentage of patients achieving remission.
Conclusions:
- Practice sites are effectively learning and applying QI methods to enhance pediatric IBD care.
- The ImproveCareNow model provides a scalable prototype for improving subspecialty care.
- Collaborative networks and data sharing are key to advancing quality in chronic disease management.
Unlabelled:
There is significant variation in diagnostic testing and treatment for inflammatory bowel disease. Quality improvement science methods can help address unwarranted variations in care and outcomes.
Methods:
The ImproveCareNow Network was established under the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the American Board of Pediatrics as a prototype for a model of improving subspecialty care that included three components: 1) creating enduring multicenter collaborative networks of pediatric subspecialists, 2) sharing of performance data collected in patient registries, and 3) training in quality improvement. The network began with a focus on improving initial diagnostic testing and evaluation, the classification of the severity and extent of disease, the detection and treatment of inadequate nutrition and growth, and the appropriate dosing of immunomodulator medications. Changes are based on an evidence-based model of chronic illness care involving the use of patient registries for population management, previsit planning, decision support, promoting self-management, and auditing of care processes.
Results:
Currently, patients are being enrolled at 23 sites. Through 2009, data have been analyzed on over 2500 patients from over 7500 visits. Initial results suggest improvements in both care processes (e.g., appropriate medication dosing and completion of a classification bundle that includes the patient's diagnosis, disease activity, distribution and phenotype, growth status, and nutrition status) and outcomes (e.g., the percentage of patients in remission).
Conclusions:
These improvements suggest that practice sites are learning how to apply quality improvement methods to improve the care of patients.
More Related Videos
09:44Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
Published on: September 11, 2012
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations